CRIS Current Research Information System

VITALI, BEATRICE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 13.212
NA - Nord America 8.510
AS - Asia 3.721
AF - Africa 558
SA - Sud America 47
OC - Oceania 17
Continente sconosciuto - Info sul continente non disponibili 8
Totale 26.073
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8.469
IT - Italia 7.174
GB - Regno Unito 1.963
CN - Cina 1.339
DE - Germania 1.048
SG - Singapore 901
SE - Svezia 892
VN - Vietnam 571
IN - India 448
FR - Francia 380
UA - Ucraina 360
RU - Federazione Russa 288
IE - Irlanda 279
TG - Togo 147
ZA - Sudafrica 143
PK - Pakistan 119
CI - Costa d'Avorio 114
EE - Estonia 109
NL - Olanda 100
CH - Svizzera 99
FI - Finlandia 91
NG - Nigeria 91
BG - Bulgaria 71
BE - Belgio 65
JO - Giordania 65
ID - Indonesia 57
IR - Iran 48
GR - Grecia 42
JP - Giappone 40
HR - Croazia 37
ES - Italia 33
PL - Polonia 31
CA - Canada 30
TR - Turchia 29
RO - Romania 24
EG - Egitto 23
SC - Seychelles 23
BR - Brasile 18
SM - San Marino 18
PT - Portogallo 17
DK - Danimarca 14
CZ - Repubblica Ceca 13
LB - Libano 13
PH - Filippine 13
DZ - Algeria 12
AU - Australia 11
HK - Hong Kong 11
RS - Serbia 11
SK - Slovacchia (Repubblica Slovacca) 11
TW - Taiwan 11
CL - Cile 9
NO - Norvegia 9
TH - Thailandia 8
AR - Argentina 7
SA - Arabia Saudita 7
UZ - Uzbekistan 7
AT - Austria 6
IQ - Iraq 6
KR - Corea 6
NZ - Nuova Zelanda 6
AL - Albania 5
MX - Messico 5
MY - Malesia 5
CO - Colombia 4
IL - Israele 4
MT - Malta 4
XK - ???statistics.table.value.countryCode.XK??? 4
AZ - Azerbaigian 3
BO - Bolivia 3
DO - Repubblica Dominicana 3
HU - Ungheria 3
KZ - Kazakistan 3
LK - Sri Lanka 3
LT - Lituania 3
LU - Lussemburgo 3
UY - Uruguay 3
AE - Emirati Arabi Uniti 2
BA - Bosnia-Erzegovina 2
BZ - Belize 2
EU - Europa 2
GH - Ghana 2
ME - Montenegro 2
MR - Mauritania 2
PE - Perù 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BD - Bangladesh 1
EC - Ecuador 1
GL - Groenlandia 1
IS - Islanda 1
LV - Lettonia 1
MD - Moldavia 1
MK - Macedonia 1
SI - Slovenia 1
SX - ???statistics.table.value.countryCode.SX??? 1
SY - Repubblica araba siriana 1
TN - Tunisia 1
Totale 26.073
Salva come PNG Salva come JPEG
Città #
Southend 1.762
Chandler 832
Singapore 769
Fairfield 759
Ashburn 678
Bologna 623
Santa Clara 473
Rome 440
Milan 439
Wilmington 421
Ann Arbor 384
Princeton 381
Seattle 376
Woodbridge 362
Houston 335
Cambridge 286
Dublin 276
Boardman 265
Dong Ket 218
Frankfurt am Main 207
Jacksonville 191
Padova 189
Nanjing 174
Westminster 156
Turin 154
Lomé 147
Naples 145
Berlin 141
Florence 116
Abidjan 114
Jinan 94
Redmond 92
New York 90
Beijing 89
Saint Petersburg 85
Medford 84
Helsinki 78
Abeokuta 73
Shenyang 70
Sofia 69
Bari 67
San Diego 66
Dearborn 65
Nanchang 64
Amman 63
Catania 60
Hebei 56
Lahore 56
Palermo 55
Falls Church 54
Bern 49
Shanghai 48
Redwood City 47
Tianjin 47
Gujranwala 46
Jakarta 46
Brussels 45
Mülheim 45
Changsha 44
Guangzhou 44
Parma 44
Munich 42
Cesena 35
Des Moines 34
Los Angeles 34
Modena 34
Verona 34
Hyderabad 32
Tukwila 32
Zhengzhou 31
Forlì 30
Hangzhou 28
Jiaxing 28
San Jose 28
Ningbo 27
Cagliari 26
Genoa 25
Brescia 24
Napoli 24
Perugia 24
Phoenix 24
Tokyo 24
Haikou 21
Pescara 21
Fuzhou 20
Kuban 20
Mumbai 20
Bremen 19
Mahé 19
Reggio Emilia 19
Taizhou 19
London 18
Norwalk 18
Paris 18
Piacenza 18
Monza 17
Thessaloniki 17
Washington 17
Boydton 16
Casalecchio di Reno 16
Totale 14.701
Salva come PNG Salva come JPEG
Nome #
VSL#3 in gravidanza: impatto sul microbiota e sulla risposta immune vaginale 4.631
STUDIO IN VITRO DELL’ATTIVITA’ ANTI-FUNGINA DI UN ESTRATTO DI SPIRULINA PLATENSIS: UN NUOVO APPROCCIO PER IL TRATTAMENTO DELLE CANDIDOSI MUCO-CUTANEE? 503
Accuratezza della spettrometria di massa MALDI-TOF nell’identificazione di specie di lattobacilli 473
In vitro anti-Candida activity of a Spirulina platensis extract: a new approach for the treatment of fungal infections? 383
NUOVI APPROCCI PER L’IDENTIFICAZIONE DI SPECIE DI LATTOBACILLI: RUOLO DELLA SPETTROMETRIA DI MASSA MALDI-TOF E DELLA METABOLOMICA 327
BIFIDOBACTERIUM BREVE BC104: ORALLY ADMINISTERED VAGINAL PROBIOTIC FOR PREVENTING GENITAL AND URINARY TRACT INFECTIONS 234
Inserti vaginali mucoadesivi costituiti da complessi di chitosano e alginato per il rilascio locale di clorexidina digluconato 229
MICROBIOTA VAGINALE IN CORSO DI INFEZIONI DEL TRATTO GENITALE 223
Identification of vaginal bacteria 216
Lactobacillus crispatus BC5 Interferes With Chlamydia trachomatis Infectivity Through Integrin Modulation in Cervical Cells. 214
Lactobacillus crispatus inhibits the infectivity of Chlamydia trachomatis elementary bodies, in vitro study 208
Insights Into Vaginal Bacterial Communities and Metabolic Profiles of Chlamydia trachomatis Infection: Positioning Between Eubiosis and Dysbiosis 196
Isolation of vaginal lactobacilli and characterization of anti-candida activity 188
Biosurfactant from vaginal Lactobacillus crispatus BC1 as a promising agent to interfere with Candida adhesion 182
An in vitro evaluation of the effect of probiotics and prebiotics on the metabolic profile of human microbiota 178
Diversity of vaginal microbiome and metabolome during genital infections 165
Spanish Broom (Spartium junceum L.) fibers impregnated with vancomycin-loaded chitosan nanoparticles as new antibacterial wound dressing: Preparation, characterization and antibacterial activity 163
Identification method based on PCR combined with automated ribotyping for tracking probiotic Lactobacillus strains colonizing the human gut and vagina 161
Characterization and Heterologous Expression of the Oxalyl Coenzyme A Decarboxylase Gene from Bifidobacterium lactis 160
Determination of antibacterial and technological properties of vaginal lactobacilli for their potential application in dairy products 160
Composizioni farmaceutiche comprendenti rifaximina, processi per la loro preparazione e loro uso nel trattamento di infezioni vaginali 159
null 156
Anti-bacterial activity of 17 strains of lactobacilli against elementary bodies of Chlamydia trachomatis 156
In vitro activity of Spirulina platensis water extract against different Candida species isolated from vulvo-vaginal candidiasis cases. 155
Evaluation of the rrn operon copy number in Bifidobacterium using real-time PCR 153
Biosurfactant for solubilization and skin permeation enhancement of hydrocortisone 150
Design and validation of a DNA-microarray for phylogenetic analysis of bacterial communities in different oral samples and dental implants 147
Rifaximin modulates the colonic microbiota of patients with Crohn’s disease: an in vitro approach using a continuous culture colonic model system 145
Bacterial concentration detection using a portable embedded sensor system for environmental monitoring 145
Chitosan/alginate complexes for vaginal delivery of chlorhexidine digluconate 145
MODULATION OF HUMAN DENDRITIC CELL PHENOTYPE AND FUNCTION BY PROBIOTIC BACTERIA 142
High-dose probiotics for the treatment of active pouchitis 142
Novel probiotic candidates for humans isolated from raw fruits and vegetables 142
Development of azithromycin-loaded microemulsions for the treatment of skin infections 141
Anti-bacterial activity of vaginal lactobacilli against Chlamydia trachomatis 139
A proteomic view of Bifidobacterium infantis generated by multi-dimensional chromatography coupled with tandem mass spectrometry 139
Investigation on the effects of antimicrobial imidazo[2,1-b]thiazole derivatives on the genitourinary microflora 138
Anti-bacterial activity of 17 strains of lactobacilli against elementary bodies of Chlamydia trachomatis 137
OralArray: a new phylogenetic DNA-microarray to characterize the oral microbiota 136
Approcci innovativi per l’identificazione di specie di lattobacilli: studio dei metaboliti mediante spettrometria di risonanza magnetica (1H-RMN) 135
Mucoadhesive chitosan/gelatin films for buccal delivery of propranolol hydrochloride 134
Protocol for the Use of PCR-Denaturing Gradient Gel Electrophoresis and Quantitative PCR to Determine Vaginal Microflora Constitution and Pathogens in Bacterial Vaginosis 133
New hybrids with 2-aminobenzothiazole and azelayl scaffolds: Synthesis, molecular docking and biological evaluation 132
Liposomes containing biosurfactants isolated from Lactobacillus gasseri exert antibiofilm activity against methicillin resistant Staphylococcus aureus strains 132
Rifaximin modulates the colonic microbiota of patients with Crohn's disease: an in vitro approach using a continuous culture colonic model system-authors' response 130
In-vitro effect of vaginal lactobacilli against group B Streptococcus 130
Effect of a synbiotic food consumption on human gut metabolic profiles evaluated by 1H Nuclear Magnetic Resonance spectroscopy 129
Novel approaches for the taxonomic and metabolic characterization of lactobacilli: Integration of 16S rRNA gene sequencing with MALDI-TOF MS and 1H-NMR 129
VAGINAL MICROBIOME FOR THE PRESERVATION OF WOMEN’S HEALTH USING FOOD STRATEGY 129
null 128
Real-time PCR quantification of bacterial adhesion to Caco-2 cells: Competition between bifidobacteria and enteropathogens 126
Quantitative variations in the vaginal bacterial population associated with asymptomatic infections: a real time PCR study 125
Interaction of probiotic Lactobacillus and Bifidobacterium strains with human intestinal epithelial cells: adhesion properties, competition against enteropathogens and modulation of IL-8 production 124
Biosurfactant loaded vesicles for the local treatment of Staphylococcus aureus skin infections 124
Polymer–lipid based mucoadhesive microspheres prepared by spray-congealing for the vaginal delivery of econazole nitrate 123
Vaginal microbiome and metabolome highlight specific signatures of bacterial vaginosis 122
null 119
null 119
Novel mixed vesicles containing lactobacilli biosurfactants for vaginal delivery of econazole nitrate 119
Use of Lactobacillus crispatus to produce a probiotic cheese as potential gender food for preventing gynaecological infections 118
High taxonomic level fingerprint of the human intestinal microbiota by Ligase Detection Reaction - Universal Array approach. 117
Dietary supplementation with probiotics during late pregnancy: outcome on vaginal microbiota and cytokine secretion 116
Efficacy and Safety of a Multistrain Probiotic Formulation Depends from Manufacturing 116
Rifaximin modulates the vaginal microbiome and metabolome in women affected by bacterial vaginosis. 115
Efficacy of rifaximin vaginal tablets in treatment of bacterial vaginosis: a molecular characterization of the vaginal microbiota 115
Studio in vitro dell’attività antimicrobica di lattobacilli vaginali nei confronti di Chlamydia trachomatis. 115
Vaginal lactobacillus inhibits HIV-1 replication in human tissues ex vivo 113
Correlation of Atopobium vaginae amount with bacterial vaginosis markers 111
Bifidobacterium lactis Enolase, surface localization and mechanism of interaction with human Plasminogen 111
Biosurfactant-based mixed vesicles for vaginal delivery of econazole 110
Vaginal Bifidobacterium breve for preventing urogenital infections: Development of delayed release mucoadhesive oral tablets 109
Insight into phenotypic and genotypic differences between vaginal Lactobacillus crispatus BC5 and Lactobacillus gasseri BC12 to unravel nutritional and stress factors influencing their metabolic activity 109
Development of microparticulate systems for intestinal delivery of Lactobacillus acidophilus and Bifidobacterium lactis 108
Electrical Impedance Spectroscopy (EIS) characterization of saline solutions with a low-cost portable measurement system 107
Evaluation of the fate of Lactobacillus crispatus BC4, carried in Squacquerone cheese, throughout the simulator of the human intestinal microbial ecosystem (SHIME) 106
CANDIDIASIS, CHLAMYDIA INFECTION, BACTERIAL VAGINOSIS: A BIOINFORMATICS APPROACH FOR PATHOLOGICAL VAGINAL MICROBIOME CHARACTERIZATION 105
Caratterizzazione molecolare di preparati probiotici farmaceutici 104
Metabolic Variability of a Multispecies Probiotic Preparation Impacts on the Anti-inflammatory Activity 103
Computer vision approach for the determination of microbial concentration and growth kinetics using a low cost sensor system 103
Method for diagnosis vaginal infections 102
Freeze-Dried Matrices Based on Polyanion Polymers for Chlorhexidine Local Release in the Buccal and Vaginal Cavities 99
Characterization of anti-Candida activity of vaginal lactobacilli 98
Vaginal microbiome signatures in Chlamydia trachomatis infected women 98
Lactobacillus crispatus to produce a functional cheese as dietary strategy to improve woman wellbeing 98
Mucoadhesive Buccal Films for Local Delivery of Lactobacillus brevis 98
Vaginal Lactobacilli Reduce Neisseria gonorrhoeae Viability through Multiple Strategies: An in Vitro Study. 98
Metabolic profiling of Candida clinical isolates of different species and infection sources 97
Genotypic and phenotypic characterization of Lactobacillus strains with antipathogenic activities 97
null 96
Anti-candida activity of hyaluronic acid combined with lactobacillus crispatus lyophilised supernatant: A new antifungal strategy 96
Impact of a synbiotic food on the gut microbial ecology and metabolic profiles 95
Isolation and characterization of biosurfactants produced by Lactobacillus gasseri of vaginal origin 95
A portable sensor system for bacterial concentration monitoring in metalworking fluids 95
Method for diagnosis vaginal infections 94
null 94
Pharmaceutical compositions comprising rifaximin, processes for their preparation and their use in the treatment of vaginal infections 94
Lactobacillus crispatus interferes with Chlamydia trachomatis infectivity through modulation of integrin exposure in cervical cells 94
New Spanish Broom dressings based on Vitamin E and Lactobacillus plantarum for superficial skin wounds 94
Probiotic and metabolic characterization of vaginal lactobacilli for a potential use in functional foods 94
Liposomes carrying lemon myrtle oil as a natural preservative system 93
Totale 18.733
Salva come PNG Salva come JPEG
Categoria #
all - tutte 62.440
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 62.440
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202.281 0 0 0 0 0 0 456 548 534 285 165 293
2020/20213.276 546 173 128 137 179 161 111 191 351 204 219 876
2021/20224.084 336 194 237 241 434 253 201 307 200 312 769 600
2022/20235.291 495 630 273 550 398 421 290 336 811 288 451 348
2023/20243.504 250 351 274 321 315 530 229 203 204 339 237 251
2024/20254.621 446 945 823 662 1.024 561 160 0 0 0 0 0
Totale 26.716